Connor, Clark & Lunn Investment Management (CC&L)’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-65,082
| Closed | -$290K | – | 1249 |
|
|
2021
Q3 | $290K | Buy |
+65,082
| New | +$290K | ﹤0.01% | 879 |
|
|
2016
Q3 | – | Sell |
-10,650
| Closed | -$146K | – | 933 |
|
|
2016
Q2 | $146K | Sell |
10,650
-58,025
| -84% | -$795K | ﹤0.01% | 775 |
|
|
2016
Q1 | $1.32M | Buy |
68,675
+35,175
| +105% | +$676K | 0.01% | 408 |
|
|
2015
Q4 | $1.17M | Buy |
+33,500
| New | +$1.17M | 0.01% | 424 |
|
|
2013
Q4 | – | Sell |
-4,300
| Closed | -$269K | – | 771 |
|
|
2013
Q3 | $269K | Buy |
4,300
+700
| +19% | +$43.8K | ﹤0.01% | 433 |
|
|
2013
Q2 | $254K | Buy |
+3,600
| New | +$254K | ﹤0.01% | 447 |
|